Japan Society of Obstetrics and Gynecology and Japan Society for Menopause and Women's Health 2017 guidelines for hormone replacement therapy
Japan Society of Obstetrics and Gynecology and Japan Society for Menopause and Women's Health 2017 guidelines for hormone replacement therapy
复制标题
DOI：
10.1111/jog.13684
复制
发表时间：
2018-08-01
影响因子：
1.6
通讯作者：
Takamatsu, Kiyoshi
中科院分区：
文献类型：
--
作者：
Okano, Hiroya;Higuchi, Tsuyoshi;Takamatsu, Kiyoshi
激素替代疗法(HRT)在维持和改善绝经后妇女的生活质量(QOL)方面发挥着重要作用。尽管有这种明显的作用，但自从2002年HRT妇女健康倡议试验研究的中期报告发表以来，HRT在日本和美国的使用一直停滞不前。日本妇产科学会和日本更年期妇女健康学会于2009年制定了激素替代疗法指南，并于2012年进行了修订，目的是整理人们对激素替代疗法的看法，使人们能够有安全感地提供或接受激素替代疗法。后来，根据HRT适应症的变化以及对其对癌症风险影响的态度，2017年再次进行了修订。随着2017年指南的建立，日本的从业者能够以更适当的判断来解决与HRT相关的各种问题。此外，可靠、安全和有效的HRT的实践有望促进进一步努力改善或维持患者的生活质量。
Hormone replacement therapy (HRT) plays a large part in maintaining and improving the quality of life (QOL) of postmenopausal women. Despite this obvious role, the use of HRT has stagnated in Japan as well as the United States, since the interim report of the HRT trial of Women's Health Initiative study was published in 2002. The Japan Society of Obstetrics and Gynecology and Japan Society for Menopause and Women's Health formulated the Guidelines for Hormone Replacement Therapy in 2009, which was subsequently revised in 2012, with the aim of organizing perceptions about HRT and allowing people to provide or receive HRT with a sense of security. Later on, in light of changes in indications for HRT and attitudes toward its impact on cancer risks, amendments were made again in 2017. With the establishment of the 2017 guidelines, practitioners in Japan are able to address various issues related to HRT with more appropriate judgment. Moreover, the practice of reliable, safe and effective HRT is expected to promote further efforts toward improvement or maintenance of QOL in patients.